rs9722

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_006272.3(S100B):​c.*37C>T variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.131 in 1,598,392 control chromosomes in the GnomAD database, including 19,105 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.21 ( 4636 hom., cov: 33)
Exomes 𝑓: 0.12 ( 14469 hom. )

Consequence

S100B
NM_006272.3 3_prime_UTR

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -2.84

Publications

53 publications found
Variant links:
Genes affected
S100B (HGNC:10500): (S100 calcium binding protein B) The protein encoded by this gene is a member of the S100 family of proteins containing 2 EF-hand calcium-binding motifs. S100 proteins are localized in the cytoplasm and/or nucleus of a wide range of cells, and involved in the regulation of a number of cellular processes such as cell cycle progression and differentiation. S100 genes include at least 13 members which are located as a cluster on chromosome 1q21; however, this gene is located at 21q22.3. This protein may function in Neurite extension, proliferation of melanoma cells, stimulation of Ca2+ fluxes, inhibition of PKC-mediated phosphorylation, astrocytosis and axonal proliferation, and inhibition of microtubule assembly. Chromosomal rearrangements and altered expression of this gene have been implicated in several neurological, neoplastic, and other types of diseases, including Alzheimer's disease, Down's syndrome, epilepsy, amyotrophic lateral sclerosis, melanoma, and type I diabetes. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.401 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
S100BNM_006272.3 linkc.*37C>T 3_prime_UTR_variant Exon 3 of 3 ENST00000291700.9 NP_006263.1 P04271A0A0S2Z4C5
S100BXM_017028424.3 linkc.*37C>T 3_prime_UTR_variant Exon 3 of 3 XP_016883913.1 P04271A0A0S2Z4C5

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
S100BENST00000291700.9 linkc.*37C>T 3_prime_UTR_variant Exon 3 of 3 1 NM_006272.3 ENSP00000291700.4 P04271
S100BENST00000367071.4 linkc.*125C>T 3_prime_UTR_variant Exon 4 of 4 1 ENSP00000356038.4 A8MRB1
S100BENST00000397648.1 linkc.*37C>T 3_prime_UTR_variant Exon 2 of 2 1 ENSP00000380769.1 P04271

Frequencies

GnomAD3 genomes
AF:
0.207
AC:
31442
AN:
152026
Hom.:
4615
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.406
Gnomad AMI
AF:
0.180
Gnomad AMR
AF:
0.142
Gnomad ASJ
AF:
0.138
Gnomad EAS
AF:
0.340
Gnomad SAS
AF:
0.217
Gnomad FIN
AF:
0.135
Gnomad MID
AF:
0.196
Gnomad NFE
AF:
0.105
Gnomad OTH
AF:
0.206
GnomAD2 exomes
AF:
0.157
AC:
38687
AN:
246542
AF XY:
0.154
show subpopulations
Gnomad AFR exome
AF:
0.412
Gnomad AMR exome
AF:
0.0879
Gnomad ASJ exome
AF:
0.140
Gnomad EAS exome
AF:
0.333
Gnomad FIN exome
AF:
0.132
Gnomad NFE exome
AF:
0.110
Gnomad OTH exome
AF:
0.138
GnomAD4 exome
AF:
0.123
AC:
177377
AN:
1446248
Hom.:
14469
Cov.:
29
AF XY:
0.124
AC XY:
89309
AN XY:
719628
show subpopulations
African (AFR)
AF:
0.425
AC:
13881
AN:
32656
American (AMR)
AF:
0.0932
AC:
4010
AN:
43006
Ashkenazi Jewish (ASJ)
AF:
0.138
AC:
3568
AN:
25922
East Asian (EAS)
AF:
0.349
AC:
13835
AN:
39590
South Asian (SAS)
AF:
0.191
AC:
16146
AN:
84640
European-Finnish (FIN)
AF:
0.131
AC:
6970
AN:
53314
Middle Eastern (MID)
AF:
0.156
AC:
890
AN:
5702
European-Non Finnish (NFE)
AF:
0.0990
AC:
109065
AN:
1101616
Other (OTH)
AF:
0.151
AC:
9012
AN:
59802
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.473
Heterozygous variant carriers
0
6619
13238
19858
26477
33096
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
4220
8440
12660
16880
21100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.207
AC:
31514
AN:
152144
Hom.:
4636
Cov.:
33
AF XY:
0.208
AC XY:
15460
AN XY:
74382
show subpopulations
African (AFR)
AF:
0.406
AC:
16854
AN:
41486
American (AMR)
AF:
0.142
AC:
2168
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.138
AC:
478
AN:
3466
East Asian (EAS)
AF:
0.340
AC:
1760
AN:
5170
South Asian (SAS)
AF:
0.217
AC:
1045
AN:
4822
European-Finnish (FIN)
AF:
0.135
AC:
1431
AN:
10592
Middle Eastern (MID)
AF:
0.207
AC:
61
AN:
294
European-Non Finnish (NFE)
AF:
0.105
AC:
7111
AN:
68000
Other (OTH)
AF:
0.209
AC:
442
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1160
2319
3479
4638
5798
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
314
628
942
1256
1570
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.146
Hom.:
1601
Bravo
AF:
0.215
Asia WGS
AF:
0.301
AC:
1042
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.90
CADD
Benign
0.24
DANN
Benign
0.67
PhyloP100
-2.8
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs9722; hg19: chr21-48019239; COSMIC: COSV52452941; API